Human Monoclonal Antibodies as Adjuvant Treatment of Chronic Hepatitis B Virus Infection

Despite the availability of an effective prophylactic vaccine leading to sterilizing immunity, hepatitis B virus (HBV) is responsible for chronic liver disease in more than 250 million individuals, potentially leading to cirrhosis and hepatocellular carcinoma. Antiviral drugs able to completely supp...

Descripción completa

Detalles Bibliográficos
Autores principales: Cerino, Antonella, Mantovani, Stefania, Mele, Dalila, Oliviero, Barbara, Varchetta, Stefania, Mondelli, Mario U.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6773823/
https://www.ncbi.nlm.nih.gov/pubmed/31608071
http://dx.doi.org/10.3389/fimmu.2019.02290

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6773823/
https://www.ncbi.nlm.nih.gov/pubmed/31608071
http://dx.doi.org/10.3389/fimmu.2019.02290

Ejemplares similares